mobile btn
Wednesday, April 21st, 2021


Ebola countermeasure has successful human trial

The Defense Threat Reduction Agency’s Joint Science and Technology Office, along with the U.S. Army Medical Research Institute of Infectious Diseases, announced this week that a compound demonstrated no adverse effects in its Phase 1 trials against the Ebola virus. The compound, GS-5734,... Read More »

Experimental Ebola antibody protects non-human primates

The National Institutes of Allergy and Infectious Diseases (NIAID) announced a discovery last week that a single monoclonal antibody isolated from a human Ebola virus disease survivor protected non-human primates from the virus. The antibody can now advance to testing in humans as a potential... Read More »

UTMB collaborates with Brazil to combat Zika virus

The Brazilian Ministry of Health announced a letter of intent on Friday to collaborate with the University of Texas Medical Branch (UTMB) at Galveston to research and develop a Zika virus vaccine The initiative of the collaborating will be directed toward the development of joint research... Read More »

INTERPOL, Barclays partner in Singapore for cyber security

INTERPOL and Barclays have announced that they will enter into a private-public partnership in order to enhance the cyber security of both institutions. As part of the agreement, Barclays will become the first financial institution to have full-time staff operating at the INTERPOL Global Complex... Read More »

NIH seeks research applications for Zika virus study

The National Institutes of Health (NIH) announced its research priorities on Friday for studies to investigate how Zika virus infection affects reproduction, pregnancy and the developing fetus. The virus is currently present in approximately 30 countries and territories, notably in Latin... Read More »

DHS works with Home Office on first responder uniform

The new Base Ensemble Project, a collaboration between the United Kingdom’s Home Office and the Department of Homeland Security Science and Technology Directorate (S&T), aims to create a uniform that will provide emergency first responders with the protection they need. First Responders often... Read More »

BARDA, HHS seek animal test models for CBRN threats

The United Stated Department of Health and Human Services (HHS) is seeking Good Laboratory Practices (GLP) facilities to support establishing new animal tests/models for the development of biological medical countermeasures against biological threats, influenza and emerging infectious... Read More »

Sandia leads efforts to update power grid

Sandia National Laboratories is participating in the Grid Modernization Laboratory Consortium’s efforts to modernize the U.S.’s electrical grid and using its expertise in grid modernization to take the lead in the area of security and resilience. “Sandia has decades of experience in... Read More »

NIH experts discuss lessons learned from Ebola outbreak

In an issue this month for the medical journal Clinical Trials, leading researchers from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), described the series of challenges and lessons learned to prevent future outbreaks. Among... Read More »

Ebola response strengthens health services in West Africa

As part of a year-in-review process, the Center for Disease Control recently outlined the steps of the Ebola recovery process in the Western African countries of Sierra Leone, Liberia and Guinea. While the disease had a deadly impact in 2015, its spread had already diminished. In January 2015,... Read More »

IT survey reveals 2016 concerns for network security

Spiceworks recently released a new survey of IT security professionals that found that internal end users - employees - are among the greatest threats to network security in the coming year. The study found that though 80 percent of the organizations surveyed in 2015 had experienced some kind... Read More »

WHO to review Merck’s ebola vaccine for emergency use

Worldwide drug manufacturer Merck recently announced that its application for Emergency Use Assessment and Listing (EUAL) for the company’s Ebola Zaire vaccine (V920) has been accepted for review by the World Health Organization. The EUAL is designed specifically to expedite the availability... Read More »